The Biotech Growth Trust PLC (BIOG) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.52 Million ≈ $-306.25 USD) by net assets (GBX257.88 Million ≈ $31.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See The Biotech Growth Trust PLC (BIOG) liquidity interval to measure how many days the company can operate on defensive assets alone.

The Biotech Growth Trust PLC - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how The Biotech Growth Trust PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

The Biotech Growth Trust PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Biotech Growth Trust PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bioter S.A. AT:BIOT	0.009x
Pool Safe Inc V:POOL	-3.557x
Netcapital Inc NASDAQ:NCPL	-0.040x
Pearl Polymers Limited NSE:PEARLPOLY	-0.121x
Future PLC LSE:FUTR	0.068x
MOBA Network publ AB ST:MOBA	0.084x
H&T Group plc LSE:HAT	0.033x
Sherpa II Holdings Corp V:SHRP	-0.046x

Annual Cash Flow Conversion Efficiency for The Biotech Growth Trust PLC (2012–2025)

The table below shows the annual cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see The Biotech Growth Trust PLC (BIOG) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX221.21 Million ≈ $26.91K	GBX-5.09 Million ≈ $-618.94	-0.023x	-95.92%
2024-03-31	GBX361.31 Million ≈ $43.96K	GBX-4.24 Million ≈ $-516.01	-0.012x	+34.18%
2023-03-31	GBX330.29 Million ≈ $40.19K	GBX-5.89 Million ≈ $-716.64	-0.018x	+42.10%
2022-03-31	GBX394.21 Million ≈ $47.96K	GBX-12.14 Million ≈ $-1.48K	-0.031x	-226.48%
2021-03-31	GBX601.47 Million ≈ $73.18K	GBX-5.67 Million ≈ $-690.36	-0.009x	+8.40%
2020-03-31	GBX365.57 Million ≈ $44.48K	GBX-3.77 Million ≈ $-458.09	-0.010x	+4.27%
2019-03-31	GBX408.88 Million ≈ $49.75K	GBX-4.40 Million ≈ $-535.23	-0.011x	-9.39%
2018-03-31	GBX417.40 Million ≈ $50.79K	GBX-4.11 Million ≈ $-499.46	-0.010x	+16.56%
2017-03-31	GBX448.41 Million ≈ $54.56K	GBX-5.29 Million ≈ $-643.03	-0.012x	+24.47%
2016-03-31	GBX378.57 Million ≈ $46.06K	GBX-5.91 Million ≈ $-718.71	-0.016x	-1283.70%
2015-03-31	GBX533.30 Million ≈ $64.89K	GBX703.00K ≈ $85.53	0.001x	+100.86%
2014-03-31	GBX340.25 Million ≈ $41.40K	GBX-52.25 Million ≈ $-6.36K	-0.154x	-3352.62%
2013-03-31	GBX244.44 Million ≈ $29.74K	GBX1.15 Million ≈ $140.41	0.005x	+267.90%
2012-03-31	GBX156.13 Million ≈ $19.00K	GBX-439.00K ≈ $-53.41	-0.003x	--

About The Biotech Growth Trust PLC

LSE:BIOG UK Asset Management

Market Cap

$3.44 Million

GBX28.30 Billion GBX

Market Cap Rank

#29233 Global

#550 in UK

Share Price

GBX1364.00

Change (1 day)

+10.71%

52-Week Range

GBX714.00 - GBX1364.00

All Time High

GBX1736.00